ISSN: 2059-3635

Journal Home

Journal Guideline

Signal Transduction and Targeted Therapy Q1 Unclaimed

Springer Nature United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Signal Transduction and Targeted Therapy is a journal indexed in SJR in Genetics and Cancer Research with an H index of 161. It is an CC BY Journal It has a price of 2490 €. It has an SJR impact factor of 12,135 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 12,135.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Genetics (Q1)

Price

2490 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Signal Transduction and Targeted Therapy

12,135

SJR Impact factor

161

H Index

365

Total Docs (Last Year)

1269

Total Docs (3 years)

61560

Total Refs

36770

Total Cites (3 years)

806

Citable Docs (3 years)

29.1

Cites/Doc (2 years)

168.66

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cell Stem Cell Q1
Nucleic Acids Research Q1
Nature Microbiology Q1
Annual Review of Medicine Q1
Annual Review of Genetics Q1

Compare this journals